A phase I study assessing the safety and performance of VB5-845D-800CW, an fluorescent agent, for the intraoperative detection of gastrointestinal cancer

Interventions: •VB5-845D-800CW •Placebo Primary outcome(s): Healthy volunteers •To determine safety and tolerability of a single dose of VB5-845D-800CW in healthy volunteers. Patients •To assess safety of different doses of a single i.v. injection of VB5-845D-800CW. Study Design: N/A: single arm study, Double blinded (masking used), Placebo, Parallel